Friday, 25 September 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 10, 2026

Subversive Capital files 'Ex-Elon' ETFs with the SEC that strip Tesla and SpaceX from the S&P 500 and Nasdaq-100

View original at finance.yahoo.com
Subversive Capital files 'Ex-Elon' ETFs with the SEC that strip Tesla and SpaceX from the S&P 500 and Nasdaq-100 If you're sickened at the thought of making the world's first trillionaire richer, a pair of proposed anti-Elon ETFs may pique your interest…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • SpaceX's inclusion in the Nasdaq-100 could attract $4.3 billion from fund managers forced to add it to their Nasdaq-related portfolios

    60% confidence

  • 36% of Americans have a 'very unfavorable opinion' of Elon Musk

    60% confidence

  • Subversive Capital's ETFs aim to provide capital appreciation by buying a broad universe of large-capitalization U.S. equity securities while excluding securities of companies founded, controlled, or led by Elon Musk, or with which Musk is otherwise primarily associated

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com
Subversive Capital files 'Ex-Elon' ETFs with the SEC that strip Tesla and SpaceX from the S&P 500 and Nasdaq-100 — Source | Via News | ViaNews EU